epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Clarinex-D 12 Hour

desloratadine/ pseudoephedrine

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  ER TAB: 2.5 mg/120 mg

allergic rhinitis, seasonal

[1 tab PO q12h]
Info: do not cut/crush/chew tab; do not exceed 5 mg/day desloratadine, 240 mg/day pseudoephedrine from all sources

renal dosing

[see below]
renal impairment: avoid use
HD/PD: not defined

hepatic dosing

[see below]
hepatic impairment: avoid use

Peds Dosing .

Dosage forms:  ER TAB: 2.5 mg/120 mg

allergic rhinitis, seasonal

[12 yo and older]
Dose: 1 tab PO q12h; Info: do not cut/crush/chew tab; do not exceed 5 mg/day desloratadine, 240 mg/day pseudoephedrine from all sources

renal dosing

[see below]
renal impairment: avoid use
HD/PD: not defined

hepatic dosing

[see below]
hepatic impairment: avoid use

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@7737b61d
  • hypersensitivity to drug or ingredient
  • hypersensitivity to loratadine
  • MAO inhibitor use within 14 days
  • pregnancy 1st trimester
  • renal impairment
  • urinary retention
  • glaucoma, angle-closure
  • CAD, severe
  • HTN, uncontrolled
  • HTN, severe
  • caution: pregnancy 2nd trimester
  • caution: pregnancy 3rd trimester
  • caution: hepatic impairment
  • caution: HTN
  • caution: cardiovascular disease
  • caution: diabetes mellitus
  • caution: hyperthyroidism
  • caution: prostatic hypertrophy

Drug Interactions .

Overview

desloratadine

antihistamine, 2nd generation

Interaction Characteristics:
    None

pseudoephedrine

alpha-1/beta-2 agonist

Interaction Characteristics:
  • hyperglycemic effects
  • hypertensive effects
  • tachycardia
  • urine pH sensitive
Other Info
  • add MAO inhibitor to Interaction Check if recent (14 days) use

Contraindicated

  • dihydroergotamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dihydroergotamine
    1 interaction

    Contraindicated

    pseudoephedrine + dihydroergotamine

    contraindicated: combo may incr. risk of severe HTN, vasospasm, ischemia (synergistic effects)

  • ergotamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ergotamine
    1 interaction

    Contraindicated

    pseudoephedrine + ergotamine

    contraindicated: combo may incr. risk of severe HTN, vasospasm, ischemia (synergistic effects)

  • isocarboxazid
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    isocarboxazid
    1 interaction

    Contraindicated

    pseudoephedrine + isocarboxazid

    contraindicated w/in 14 days of isocarboxazid use: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • phenelzine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phenelzine
    1 interaction

    Contraindicated

    pseudoephedrine + phenelzine

    contraindicated w/in 14 days of phenelzine use: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tranylcypromine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    tranylcypromine
    1 interaction

    Contraindicated

    pseudoephedrine + tranylcypromine

    contraindicated w/in 14 days of tranylcypromine use: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

Avoid/Use Alternative

  • albuterol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    albuterol
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + albuterol

    use alternative or monitor BP, HR w/ oral albuterol; risk may be lower w/ inhaled albuterol: combo may incr. risk of HTN, tachycardia (additive effects)

  • cocaine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    cocaine
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + cocaine

    use alternative or monitor BP, HR, ECG: combo may incr. risk of severe vasoconstriction, HTN, tachycardia, arrhythmias (additive effects)

  • ephedra
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + ephedra

    avoid combo: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects, ephedra may contain pseudoephedrine)

  • epinephrine inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • furosemide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + furosemide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • landiolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    landiolol
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + landiolol

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • methylergonovine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methylergonovine
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + methylergonovine

    consider alternative or monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (synergistic effects)

  • midodrine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • ozanimod
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ozanimod
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + ozanimod

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • phenylephrine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phenylephrine
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + phenylephrine

    avoid combo: combo may incr. risk of HTN, tachycardia, other cardiovascular and CNS stimulatory effects (additive effects, duplicate therapy)

  • procarbazine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    procarbazine
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + procarbazine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • pseudoephedrine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    pseudoephedrine
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + pseudoephedrine

    avoid combo: combo may incr. risk of HTN, other cardiovascular and CNS stimulatory effects (additive effects, duplicate therapy)

  • rasagiline
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    rasagiline
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + rasagiline

    avoid combo w/in 14 days of rasagiline use: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • safinamide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    safinamide
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + safinamide

    avoid combo w/in 14 days of safinamide use: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • selegiline
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    selegiline
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + selegiline

    avoid combo w/in 14 days of selegiline use: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • selegiline transdermal
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    selegiline transdermal
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + selegiline transdermal

    avoid combo w/in 2wk of selegiline use: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • yohimbe
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    yohimbe
    1 interaction

    Avoid/Use Alternative

    pseudoephedrine + yohimbe

    avoid combo w/in 14 days of yohimbe use: combo may incr. risk of HTN, tachycardia (additive effects)

Monitor/Modify Tx

  • abiraterone acetate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • acarbose
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acebutolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + acebutolol

    monitor BP: combo may decr. antihypertensive efficacy, exaggerate HTN response (antagonistic effects)

  • albuterol inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + albuterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • aliskiren
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • alogliptin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • aluminum hydroxide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    aluminum hydroxide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + aluminum hydroxide

    monitor BP, HR: combo may incr. pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • amiloride
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amitriptyline
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + amitriptyline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • amlodipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amoxapine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + amoxapine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • amphetamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + amphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • angiotensin II
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprocitentan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + arformoterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • armodafinil
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + armodafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • asciminib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atenolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atogepant
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + atogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atomoxetine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + atomoxetine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • atropine ophthalmic
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • axitinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benazepril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + benzphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • betamethasone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + betamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bexagliflozin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + bexagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • bismuth subsalicylate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + bisoprolol

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brigatinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bromocriptine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + bromocriptine

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy; may incr. risk of HTN, tachycardia (antagonistic effects; mechanism unknown)

  • budesonide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bumetanide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + bumetanide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bupropion
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cabozantinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + caffeine

    monitor BP, HR; avoid excessive caffeine intake: combo may incr. risk of HTN, tachycardia (additive effects)

  • caffeine citrate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + caffeine citrate

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • calcium carbonate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    calcium carbonate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + calcium carbonate

    monitor BP, HR: combo may increase pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • canagliflozin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + canagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • candesartan cilexetil
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + cannabis

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • captopril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + carfilzomib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • carvedilol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • celecoxib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • chlorothiazide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + chlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorthalidone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + chlorthalidone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clevidipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clomipramine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + clomipramine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • clonidine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • colesevelam
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • copanlisib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + corticotropin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cortisone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + cortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cyclosporine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + cyclosporine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • danazol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + danazol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dapagliflozin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dapagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • darbepoetin alfa
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • deflazacort
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + deflazacort

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desipramine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + desipramine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • desmopressin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + desmopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desvenlafaxine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dexamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexmethylphenidate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dexmethylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextroamphetamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dextroamphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular and CNS stimulatory effects (additive effects)

  • dichlorphenamide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dichlorphenamide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dichlorphenamide

    monitor BP, HR: combo may incr. pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • diclofenac
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diethylpropion
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + diethylpropion

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • diflunisal
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diltiazem
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dobutamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dopamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxepin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + doxepin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dronabinol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dronabinol

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • droxidopa
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • dulaglutide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • eletriptan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • empagliflozin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + empagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • enalapril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ephedrine injection

    monitor BP, HR: combo may incr. risk of HTN, arrhythmias, tachycardia (additive effects)

  • ephedrine oral
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ephedrine oral

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • epinephrine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + epinephrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • eplerenone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eptinezumab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ertugliflozin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ertugliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • esketamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ethacrynic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethanol (alcoholic beverage)
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • exenatide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • felodipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenoldopam
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fludrocortisone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fludrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flurbiprofen
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • formoterol inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + formoterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • fosinopril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fremanezumab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • galcanezumab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • glimepiride
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glycopyrrolate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    glycopyrrolate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + glycopyrrolate

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • guanfacine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hoodia
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + hoodia

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • hydralazine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + hydrochlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + hydrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxocobalamin IV
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hyoscyamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    hyoscyamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + hyoscyamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ibrutinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • imipramine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + imipramine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • indapamide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + indapamide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • indomethacin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • insulin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + insulin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • irbesartan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isradipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ketamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other sympathomimetic adverse effects (additive effects)

  • ketoprofen
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • leflunomide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenvatinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levalbuterol inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + levalbuterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • levomilnacipran
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + levomilnacipran

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • levothyroxine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + levothyroxine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • licorice
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lifileucel
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lifileucel

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • linagliptin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • linezolid
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    linezolid
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + linezolid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • liothyronine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + liothyronine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • liraglutide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + liraglutide

    monitor HR, glucose in type 2 diabetes mellitus pts: combo may incr. risk of tachycardia; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • lisdexamfetamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lisdexamfetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular and CNS stimulatory effects (additive effects)

  • lisinopril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lixisenatide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorlatinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lorlatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • losartan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + lumacaftor/ ivacaftor

    monitor BP: combo may incr. risk of HTN (additive effects)

  • luspatercept
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium carbonate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    magnesium carbonate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + magnesium carbonate

    monitor BP, HR: combo may increase pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • magnesium hydroxide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    magnesium hydroxide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + magnesium hydroxide

    monitor BP, HR: combo may increase pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • magnesium salicylate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • meclofenamate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metformin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methamphetamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + methamphetamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyldopa
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylphenidate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + methylphenidate

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, CNS stimulatory effects (additive effects)

  • methylprednisolone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + methylprednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + metolazone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoprolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • miglitol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milnacipran
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + milnacipran

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • minoxidil
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • modafinil
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + modafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • moexipril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nabumetone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nateglinide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • naxitamab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicardipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nifedipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nimodipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norepinephrine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • nortriptyline
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + nortriptyline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • obinutuzumab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + olodaterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • orphenadrine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    orphenadrine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + orphenadrine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • osilodrostat
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxaprozin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline ophthalmic
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    oxymetazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + oxymetazoline ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects, duplicate therapy)

  • oxytocin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • pazopanib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + pexidartinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phendimetrazine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phendimetrazine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenoxybenzamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phenoxybenzamine

    monitor BP, HR: combo may incr. risk of hypotension, tachycardia (paradoxical effects, unopposed stimulation of beta receptors)

  • phentermine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phentermine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, CNS stimulatory effects (additive effects)

  • phentolamine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phentolamine

    monitor BP, HR: combo may incr. risk of hypotension, tachycardia (paradoxical effects, unopposed stimulation of beta receptors)

  • phenylephrine injection
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects, duplicate therapy)

  • phenylephrine nasal
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects, duplicate therapy)

  • phenylephrine ophthalmic
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phenylephrine ophthalmic

    monitor BP, HR; risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenylephrine rectal
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects, duplicate therapy)

  • pindolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pioglitazone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • piroxicam
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponatinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pralsetinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pramlintide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + prednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prednisone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + prednisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • propranolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • protriptyline
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + protriptyline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • quetiapine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramipril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • regorafenib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • repaglinide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rimegepant
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ropinirole
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rosiglitazone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + rotigotine transdermal

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • salmeterol inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + salmeterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • salsalate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + salsalate

    monitor BP w/ high-dose salsalate: combo may incr. risk of HTN (additive effects)

  • saxagliptin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selpercatinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • semaglutide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • siponimod
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sitagliptin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium bicarbonate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    sodium bicarbonate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + sodium bicarbonate

    monitor BP, HR: combo may incr. pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • sodium citrate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    sodium citrate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + sodium citrate

    monitor BP, HR: combo may incr. pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • solriamfetol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + solriamfetol

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • sorafenib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sulindac
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + tacrolimus

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tagraxofusp
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + terbutaline

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • teriflunomide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • thyroid
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + thyroid

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • timolol
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tirzepatide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • topiramate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    topiramate
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + topiramate

    monitor BP, HR: combo may incr. pseudoephedrine levels, risk of HTN, tachycardia, other adverse effects (renal excretion decreased at higher urine pH)

  • torsemide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + torsemide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trametinib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + triamcinolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • triamterene
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trimipramine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + trimipramine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trospium
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    trospium
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + trospium

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ubrogepant
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ubrogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vadadustat
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + vamorolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vandetanib
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • venlafaxine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + vilanterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • viloxazine
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + viloxazine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • voclosporin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zavegepant
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    pseudoephedrine + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

Caution Advised

  • acetazolamide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    acetazolamide
    1 interaction

    Caution Advised

    pseudoephedrine + acetazolamide

    caution advised: combo may incr. pseudoephedrine levels, risk of adverse effects (renal excretion may be decreased in alkaline urine)

  • ascorbic acid (vitamin C)
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    ascorbic acid (vitamin C)
    1 interaction

    Caution Advised

    pseudoephedrine + ascorbic acid (vitamin C)

    caution advised: combo may decr. pseudoephedrine levels, efficacy (renal excretion increased in acidic urine)

  • digoxin
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    digoxin
    1 interaction

    Caution Advised

    pseudoephedrine + digoxin

    caution advised: combo with decongestants may incr. risk of cardiac arrhythmias (additive effects)

  • methazolamide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    methazolamide
    1 interaction

    Caution Advised

    pseudoephedrine + methazolamide

    caution advised: combo may incr. pseudoephedrine levels, risk of adverse effects (renal excretion decreased in alkaline urine)

  • potassium acid phosphate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    potassium acid phosphate
    1 interaction

    Caution Advised

    pseudoephedrine + potassium acid phosphate

    caution advised: combo may decr. pseudoephedrine efficacy (renal excretion increased in acidic urine)

  • potassium bicarbonate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    potassium bicarbonate
    1 interaction

    Caution Advised

    pseudoephedrine + potassium bicarbonate

    caution advised w/ frequent or high-dose urinary alkalinizers: combo may incr. pseudoephedrine levels, risk of adverse effects (renal excretion decreased in alkaline urine)

  • potassium citrate
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    potassium citrate
    1 interaction

    Caution Advised

    pseudoephedrine + potassium citrate

    caution advised w/ frequent or high-dose potassium citrate: combo may incr. pseudoephedrine levels, risk of adverse effects (renal excretion decreased in alkaline urine)

  • zonisamide
  • Clarinex-D 12 Hour (desloratadine/ pseudoephedrine)
    +
    zonisamide
    1 interaction

    Caution Advised

    pseudoephedrine + zonisamide

    caution advised: combo may incr. pseudoephedrine levels, risk of adverse effects (renal excretion decreased in alkaline urine)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@157fcd80
  • arrhythmia
  • HTN
  • cardiovascular collapse
  • seizures
  • hypersensitivity reaction
  • anaphylaxis
  • skin reaction, severe
  • hepatitis

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@222756f1
  • xerostomia
  • headache
  • insomnia
  • fatigue
  • pharyngitis
  • somnolence
  • nausea
  • dizziness
  • hyperactivity
  • anorexia
  • nervousness
  • palpitations
  • tachycardia

Safety/Monitoring .

Monitoring Parameters
no routine tests recommended

Pregnancy/Lactation .

Pregnancy

Clinical Summary

desloratadine: may use during pregnancy; no human data available, though risk of fetal harm not expected based on limited human data with loratadine

pseudoephedrine: avoid use in 1st trimester, weigh risk/benefit in 2nd and 3rd trimesters; possible risk of teratogenicity, including gastroschisis, small intestinal atresia, and hemifacial microsomia based on limited human data; risk of vasoconstriction based on animal data and drug's mechanism of action

Lactation

Clinical Summary

desloratadine: may use short-term while breastfeeding, otherwise weigh risk/benefit; no known risk of infant harm based on limited human data with loratadine; inadequate human data available, though theoretical risk of decr. milk production based on decr. prolactin levels

pseudoephedrine: may occasionally use while breastfeeding, though weigh risk/benefit if poor milk production; no known risk of infant harm based on limited human data; decr. milk production based on limited human data

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@4ecd4440

Metabolism: for desloratadine: liver extensively; CYP450: unknown; Info: active metabolite; for pseudoephedrine: liver partially; CYP450: unknown; Info: active metabolite

Excretion: for desloratadine: urine, feces; Half-life: 27h; for pseudoephedrine: urine (70-90% unchanged); Half-life: 9-16h; Info: decr. excretion in alkaline urine

Subclass: Antihistamine/Decongestant Combos

Mechanism of Action
for desloratadine: selectively antagonizes peripheral histamine H1 receptors; for pseudoephedrine: stimulates smooth muscle alpha adrenergic receptors, producing vasoconstriction and reducing nasal congestion (sympathomimetic)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Organon

com.epocrates.rxweb.beans.DrugOtherInfoBean@48094da

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet, extended release:

  • 2.5 mg/120 mg (60 ea): $317.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information